Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Phenotype C0011847|diabetes
Sentences 14
PubMedID- 23173135 This differential treatment time window between cases and controls likely led to the apparent increased risk of hepatocellular carcinoma with diet-controlled diabetes and consequently to an apparent decreased risk with metformin and thiazolidinediones.
PubMedID- 23788857 A man aged 56 years old, suffering from alcohol-induced cirrhosis, hypertension and insulin-treated type 2 diabetes was diagnosed with hepatocellular carcinoma (hcc) in early august 2008 on the basis of biopsy of the dominant tumorous lesion located in the right liver lobe.
PubMedID- 20734163 To clarify this point, we analyze the therapeutic effect of intra-arterial chemotherapy in unrespectable hepatocellular carcinoma patients with or without diabetes mellitus.
PubMedID- 25641920 Hyperglycemia is an important factor for chemoresistance of hepatocellular carcinoma patients with diabetes to therapeutics.
PubMedID- 23236362 Epidemiological studies highlight an increased prevalence of chronic liver disease and hepatocellular carcinoma in patients with type 2 diabetes [10], [12].
PubMedID- 21544812 Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies.
PubMedID- 24386416 diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area.
PubMedID- 20559430 This also provides biological plausibility into the increased risk of hepatocellular carcinoma in patients with diabetes according to cohort studies [50].
PubMedID- 23209929 The elevated incidence of hepatocellular carcinoma in patients with diabetes could be related to the common association of diabetes with nonalcoholic fatty liver disease, and with viral hepatic disease, which are both risk factors for hepatic cancer [3].
PubMedID- 26252899 This finding may help explain epidemiological studies from populations across the world that have reported a twofold to fourfold increase in risk of developing cirrhosis, liver failure and hepatocellular carcinoma in people with type 2 diabetes [1,6].
PubMedID- 20460909 In addition, there is growing evidence linking obesity and type 2 diabetes with hepatocellular carcinoma in subjects with chronic viral hepatitis.
PubMedID- 23244117 Association of type ii diabetes mellitus with hepatocellular carcinoma occurrence--a case control study from kathmandu valley.
PubMedID- 25117675 Non-alcoholic steatohepatitis (nash) has emerged as a common cause of chronic liver disease and virus-independent hepatocellular carcinoma (hcc) in patients with obesity, diabetes, and metabolic syndrome.
PubMedID- 23613635 Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.

Page: 1